Condition
Irregular Menstrual Cycle
Total Trials
4
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
50%
2 of 4 completed with results
Key Signals
2 with results100% success
Data Visualizations
Phase Distribution
Trial Status
Completed4
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT01711216CompletedPrimary
Treatment Regimen in Menstrual Cycle Regularization and Persistence in Routine Clinical Practice in Russia, Ukraine, Kazakhstan and Uzbekistan
NCT02029144Completed
Observational Study of Dydrogesterone in Cycle Regularization
NCT01525563CompletedPrimary
Duphaston in Cycle Regularization: A Post-marketing, Prospective, Multicenter, Observational Study
NCT01604603Completed
The Clinical and Biochemical Characteristics in Women With Different Menstrual Pattern
Showing all 4 trials